Next Article in Journal / Special Issue
Remodeling and Control of Homologous Recombination by DNA Helicases and Translocases that Target Recombinases and Synapsis
Previous Article in Journal
Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene
Previous Article in Special Issue
Replication-Associated Recombinational Repair: Lessons from Budding Yeast

Targeting DNA Replication Stress for Cancer Therapy

Division of Hematology, Department of Internal Medicine, Oncology and Blood and Marrow Transplantation, Holden Comprehensive Cancer Center, University of Iowa Carver College of Medicine, 200 Hawkins Drive, Iowa City, IA 52242, USA
Division of Cancer Biology, Department of Radiation Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, 1365C Clifton Road NE, Atlanta, GA 30322, USA
Authors to whom correspondence should be addressed.
Academic Editor: Richard T. Pomerantz
Genes 2016, 7(8), 51;
Received: 9 June 2016 / Revised: 6 August 2016 / Accepted: 15 August 2016 / Published: 19 August 2016
(This article belongs to the Special Issue Replication and Transcription Associated DNA Repair)
The human cellular genome is under constant stress from extrinsic and intrinsic factors, which can lead to DNA damage and defective replication. In normal cells, DNA damage response (DDR) mediated by various checkpoints will either activate the DNA repair system or induce cellular apoptosis/senescence, therefore maintaining overall genomic integrity. Cancer cells, however, due to constitutive growth signaling and defective DDR, may exhibit “replication stress” —a phenomenon unique to cancer cells that is described as the perturbation of error-free DNA replication and slow-down of DNA synthesis. Although replication stress has been proven to induce genomic instability and tumorigenesis, recent studies have counterintuitively shown that enhancing replicative stress through further loosening of the remaining checkpoints in cancer cells to induce their catastrophic failure of proliferation may provide an alternative therapeutic approach. In this review, we discuss the rationale to enhance replicative stress in cancer cells, past approaches using traditional radiation and chemotherapy, and emerging approaches targeting the signaling cascades induced by DNA damage. We also summarize current clinical trials exploring these strategies and propose future research directions including the use of combination therapies, and the identification of potential new targets and biomarkers to track and predict treatment responses to targeting DNA replication stress. View Full-Text
Keywords: DNA replication stress; cancer; targeted therapy DNA replication stress; cancer; targeted therapy
Show Figures

Figure 1

MDPI and ACS Style

Zhang, J.; Dai, Q.; Park, D.; Deng, X. Targeting DNA Replication Stress for Cancer Therapy. Genes 2016, 7, 51.

AMA Style

Zhang J, Dai Q, Park D, Deng X. Targeting DNA Replication Stress for Cancer Therapy. Genes. 2016; 7(8):51.

Chicago/Turabian Style

Zhang, Jun, Qun Dai, Dongkyoo Park, and Xingming Deng. 2016. "Targeting DNA Replication Stress for Cancer Therapy" Genes 7, no. 8: 51.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop